A recent study published in the British Medical Journal (BMJ) reveals what happens to the body after individuals stop taking popular weight-loss drugs like Ozempic, which use GLP-1 agonists such as semaglutide.

• Participants who stopped weight-loss medication regained an average of 0.4 kilograms each month, totaling nearly 10 kilograms in the first year.
• The study analyzed data from 6,000 adults using medication and 3,000 following behavioral programs.
• Risk factors for diabetes and heart disease returned to pre-treatment levels within less than two years after quitting medication.